122: Patient stratification reveals the molecular basis of disease co-occurrences

Urda-García B et al., PNAS - This episode discusses a PNAS study that builds disease similarity networks from public RNA-seq data and shows that stratifying patients into 'meta-patients' uncovers molecular mechanisms behind many medically observed comorbidities. Key terms: transcriptomics, comorbidity, disease networks, patient stratification, immune system.

Study Highlights:
The authors used uniformly processed RNA-seq from 45 diseases to build a Disease Similarity Network (DSN) and a Stratified Similarity Network (SSN) that includes patient subgroups (meta-patients). The DSN recapitulates 46.2% of epidemiological comorbidities and the SSN raises recall to 64.13%, while maintaining precision. Most captured comorbidities implicate immune system pathways and shared dysregulated Reactome pathways such as ECM, metabolism, and signal transduction. Meta-patients reveal subgroup-specific comorbidity links and increase detection power, especially for heterogeneous diseases.

Conclusion:
Gene expression–based disease networks, enhanced by patient stratification, explain a large fraction of known comorbidities and provide molecular hypotheses—predominantly immune-related—that can guide personalized management and further study.

Music:
Enjoy the music based on this article at the end of the episode.

Article title:
Patient stratification reveals the molecular basis of disease co- occurrences

First author:
Urda-García B

Journal:
PNAS

DOI:
10.1073/pnas.2421060122

Reference:
Urda-García B, Sánchez-Valle J, Lepore R, Valencia A. Patient stratification reveals the molecular basis of disease co-occurrences. PNAS. 2025;122(35):e2421060122. doi:10.1073/pnas.2421060122

License:
This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/

Support:
Base by Base – Stripe donations: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00

Official website https://basebybase.com

On PaperCast Base by Base you'll discover the latest in genomics, functional genomics, structural genomics, and proteomics.

Episode link: https://basebybase.com/episodes/patient-stratification-reveals-the-molecular-basis-of-disease-co-occurrences

QC:
This episode was checked against the original article PDF and publication metadata for the episode release published on 2025-08-30.

QC Scope:
- article metadata and core scientific claims from the narration
- excludes analogies, intro/outro, and music
- transcript coverage: Audited sections cover: comorbidity concept, differential expression strategy, DSN/SSN methodology, meta-patient stratification, key molecular mechanisms (immune system and ECM), inverse comorbidities (Huntington's with cancers), Down syndrome heterogeneity, and the public web resource.
- transcript topics: Comorbidity concepts and data sources; RNA-seq differential expression and disease fingerprinting; Disease Similarity Network (DSN) construction; Stratified Similarity Network (SSN) and meta-patients; Immune system and ECM pathways in comorbidities; Inverse comorbidity and Huntington's disease example

QC Summary:
- factual score: 10/10
- metadata score: 10/10
- supported core claims: 6
- claims flagged for review: 0
- metadata checks passed: 4
- metadata issues found: 0

Metadata Audited:
- article_doi
- article_title
- article_journal
- license

Factual Items Audited:
- DSN recalls 46.2% of known epidemiological comorbidities
- SSN recalls 64.1% (meta-patients) of epidemiological associations
- 95.2% of epidemiological interactions share at least one immune system pathway
- ECM pathways and related metabolic/signal pathways are commonly altered in comorbidities
- Huntington's disease shows inverse comorbidity with certain cancers; ~85% of shared pathways are oppositely regulated
- Huntington's immune signaling includes increased IL-12 and complement cascade activation

QC result: Pass.